The company recognized an impairment loss on investment securities due to a significant decline in fair value compared to acquisition cost. The impairment loss of 952 million yen was recorded as an extraordinary loss in the third quarter of fiscal year ending March 2026, affecting both individual and consolidated financial statements.
Β₯952M
βΊ
Summary
The company recognized an impairment loss on investment securities due to a significant decline in fair value compared to acquisition cost. The impairment loss of 952 million yen was recorded as an extraordinary loss in the third quarter of fiscal year ending March 2026, affecting both individual and consolidated financial statements.